Market Overview

Benzinga's Top Initiations

Related AKBA
Stocks Hitting 52-Week Lows
Stocks Hitting 52-Week Lows
Related AI
Is Sallie Mae (SLM) Likely to Miss Earnings This Season?
E*TRADE Financial Continues to Reduce Balance Sheet Risk - Analyst Blog

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Latest Ratings for AKBA

DateFirmActionFromTo
Apr 2014Credit SuisseInitiates Coverage onOutperform
Apr 2014NomuraInitiates Coverage onBuy
Apr 2014Morgan StanleyInitiates Coverage onOverweight

View More Analyst Ratings for AKBA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AI + AKBA)

Around the Web, We're Loving...

Get Benzinga's Newsletters